Results 41 to 50 of about 31,835 (290)

Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis [PDF]

open access: yes, 2015
BACKGROUND: Peritoneal metastasis (PM) is considered a terminal and incurable disease. In the last 30 years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically changed the therapeutic approach for these patients ...
Accarpio, Fabio   +8 more
core   +2 more sources

Primary extrauterine cystic low-grade endometrioid stromal sarcoma mimicking stromal endometriosis. A case report emphasizing the differential diagnosis and its potential local aggressive behavior

open access: yesPolish Journal of Pathology, 2020
Genital and pelvic endometriosis is a frequently encountered lesion and its importance rely on associated symptoms and its propensity for malignant transformation.
Simona Stolnicu   +4 more
doaj   +1 more source

Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature

open access: yesAnnals of Translational Medicine, 2020
Background Low-grade endometrial stromal sarcoma (LGESS) is the second most common malignant mesenchymal tumor of the uterus which usually affects young women.
Yawen Zheng   +3 more
semanticscholar   +1 more source

Sarcoma de estroma endometrial. Estudio clinicopatológico e inmunofenotípico de 5 casos [PDF]

open access: yes, 2007
Introducción: El sarcoma de estroma endometrial uterino es un tumor muy poco frecuente con una incidencia de 0,4 -3,4 por 100.000 mujeres, comprende menos del 1% de tumores malignos ginecológicos y el 2-5% de tumores malignos uterinos, siendo el tercer ...
Llombart Bosch, Antonio   +4 more
core   +1 more source

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. [PDF]

open access: yes, 2016
BackgroundHER2/neu overexpression and/or amplification has been widely studied in a number of solid tumors, primarily in the breast. In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti ...
Apple, Sophia K   +5 more
core   +2 more sources

Extrauterine Low-Grade Endometrial Stromal Sarcoma

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2005
Objective: Endometrial stromal sarcoma is a rare cancer that accounts for 0.2% or less of all female genital tract malignancies. We present a case of extrauterine low-grade endometrial stromal sarcoma arising from endometriosis, which was managed by ...
Yu-Ju Chen   +2 more
doaj   +1 more source

Molecular pathogenesis and prognostication of "low‐grade'' and "high‐grade" endometrial stromal sarcoma

open access: yesGenes, Chromosomes and Cancer, 2020
Endometrial stromal sarcomas (ESS) are a heterogeneous group of rare mesenchymal cancers. Considerable knowledge has been gained in recent years about the molecular characteristics of these cancers, which helps to classify them in a more meaningful ...
F. Micci, S. Heim, I. Panagopoulos
semanticscholar   +1 more source

Immunohistochemistry of endometrial stromal sarcoma

open access: yesHuman Pathology, 1991
Twenty-three cases (12 low grade, 11 high grade) of endometrial stromal sarcoma were studied with monoclonal antibodies to vimentin, keratin, desmin, muscle actin, epithelial membrane antigen, and collagen type IV, using the avidin-biotin immunoperoxidase method. Tumors were highly variable in the expression of these antigens.
Anwar Farhood   +3 more
openaire   +3 more sources

Clinicopathological and molecular markers associated with prognosis and treatment effectiveness of endometrial stromal sarcoma: a retrospective study in China [PDF]

open access: yes, 2013
PURPOSE: To evaluate the clinicopathological and immunophenotypic characteristics of endometrial stromal sarcoma (ESS) in China. METHODS AND MATERIALS: Seventy-two consecutive ESS cases treated between 1995 and 2009 were retrospectively reviewed. RESULTS:
Jia-xin Lin   +7 more
core   +1 more source

Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma [PDF]

open access: yesCancer, 1982
U.T.M.D. Anderson Hospital cases filed as endometrial sarcoma were reviewed. Malignant mixed Müllerian tumors, Müllerian adenosarcomas, and poorly differentiated sarcomas of uncertain origin were excluded, and a minimum of 36 months follow-up was required. On pathologic examination, the remaining cases fell into two distinct groups: endometrial stromal
openaire   +3 more sources

Home - About - Disclaimer - Privacy